BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16716462)

  • 1. Enhanced antigen-specific antibody production following polyplex-based DNA vaccination via the intradermal route in mice.
    Kawase A; Isaji K; Yamaoka A; Kobayashi N; Nishikawa M; Takakura Y
    Vaccine; 2006 Jul; 24(27-28):5535-45. PubMed ID: 16716462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.
    Guan X; Nishikawa M; Takemoto S; Ohno Y; Yata T; Takakura Y
    J Gene Med; 2010 Mar; 12(3):301-9. PubMed ID: 20084616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of local disposition and gene expression characteristics of plasmid DNA following intramuscular administration by complexation with cationic macromolecule.
    Kawase A; Kobayashi N; Isaji K; Nishikawa M; Takakura Y
    Int J Pharm; 2005 Apr; 293(1-2):291-301. PubMed ID: 15778067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
    Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
    J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
    Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M
    Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
    Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
    J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations.
    Bal SM; Slütter B; van Riet E; Kruithof AC; Ding Z; Kersten GF; Jiskoot W; Bouwstra JA
    J Control Release; 2010 Mar; 142(3):374-83. PubMed ID: 19932723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA tattoo vaccination: effect on plasmid purity and transfection efficiency of different topoisoforms.
    Quaak SG; van den Berg JH; Oosterhuis K; Beijnen JH; Haanen JB; Nuijen B
    J Control Release; 2009 Oct; 139(2):153-9. PubMed ID: 19580829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.
    Gaffal E; Schweichel D; Tormo D; Steitz J; Lenz J; Basner-Tschakarjan E; Limmer A; Tüting T
    Eur J Cell Biol; 2007 Dec; 86(11-12):817-26. PubMed ID: 16928407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antibody response by high mobility group box protein-1-based DNA immunization.
    Kimura R; Shiibashi R; Suzuki M; Hayashizaki Y; Chiba J
    J Immunol Methods; 2010 Sep; 361(1-2):21-30. PubMed ID: 20470779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.
    Carstens MG; Camps MG; Henriksen-Lacey M; Franken K; Ottenhoff TH; Perrie Y; Bouwstra JA; Ossendorp F; Jiskoot W
    Vaccine; 2011 Jun; 29(29-30):4761-70. PubMed ID: 21565240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity].
    Tan XH; Wan YH
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):399-403. PubMed ID: 17456382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination.
    Jamali A; Holtrop M; de Haan A; Hashemi H; Shenagari M; Memarnejadian A; Roohvand F; Sabahi F; Kheiri MT; Huckriede A
    Immunol Lett; 2012; 148(1):77-82. PubMed ID: 22981929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of different DNA delivery systems for protection against respiratory syncytial virus infection in the murine model: gene-gun delivery induces IgG in the lung.
    Tree JA; Bembridge G; Hou S; Taylor G; Fashola-Stone E; Melero J; Cranage MP
    Vaccine; 2004 Jun; 22(19):2438-43. PubMed ID: 15193407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular basis of immune induction at mucosal surfaces by DNA vaccination.
    Barnfield C; Brew R; Tilling R; Rae A; Wheeler C; Klavinskis LS
    Dev Biol (Basel); 2000; 104():159-64. PubMed ID: 11713815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of both cellular and humoral responses to genetic immunization by co-administration of an antigen-expressing plasmid and a plasmid encoding the pro-apoptotic protein Bax.
    Kinsey BM; Marcelli M; Song L; Bhogal BS; Ittmann M; Orson FM
    J Gene Med; 2004 Apr; 6(4):445-54. PubMed ID: 15079819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine.
    Yoshikawa T; Imazu S; Gao JQ; Hayashi K; Tsuda Y; Shimokawa M; Sugita T; Niwa T; Oda A; Akashi M; Tsutsumi Y; Mayumi T; Nakagawa S
    Biochem Biophys Res Commun; 2004 Dec; 325(2):500-5. PubMed ID: 15530420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of apoptosis-resistant T cell-activating dendritic cells promotes T helper type-2 response and IgE antibody production.
    Arques JL; Regoli M; Bertelli E; Nicoletti C
    Mol Immunol; 2008 Apr; 45(8):2177-86. PubMed ID: 18237782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating specific priming of immune effector functions by DNA-based vaccination strategies.
    Reimann J; Schirmbeck R
    Dev Biol (Basel); 2000; 104():15-24. PubMed ID: 11713813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity.
    Westermann J; Nguyen-Hoai T; Baldenhofer G; Höpken UE; Lipp M; Dörken B; Pezzutto A
    Cancer Gene Ther; 2007 Jun; 14(6):523-32. PubMed ID: 17384577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.